Echelon Capital Markets analyst Stefan Quenneville continues to like Valeo Pharma (Valeo Pharma Stoc... Read More
Investors should be gearing up for some movement in the biotech space, says iA Capital Markets analy... Read More
$0.50 to $0.70 per share — that’s been the range over the past 12 months for Canadian specialty ... Read More
Investors looking for growth-oriented stocks in the Canadian pharmaceutical space should be thinking... Read More
Research Capital Corp analyst André Uddin likes the new move by Canadian specialty pharma company V... Read More
The Healthcare space has taken it on the chin this year, as stocks across the board are down by well... Read More
Despite a target drop, Chelsea Stellick of iA Capital Markets isn’t panicking about Valeo Pharma I... Read More
It’s been an uncomfortable stretch for fans of Healthcare stocks, with names across the board losi... Read More
Research Capital Corporation analyst André Uddin is holding onto his value perception of Valeo Phar... Read More
There’s still good long-term growth prospects to the name but Research Capital Corporation ana... Read More
Paradigm Capital analyst Scott McAuley makes the case for investing in Canadian pharmaceutical compa... Read More
Valeo Pharma (Valeo Pharma Stock Quote, Chart, News, Analysts, Financials CSE:VPH) is poised to do ... Read More
Chelsea Stellick of iA Capital Markets continues to see value in Valeo Pharma Inc. (Valeo Pharma Sto... Read More
Paradigm Capital analyst Scott McAuley is still excited about Valeo Pharma Inc. (Valeo Pharma Stock ... Read More
iA Capital Markets analyst Chelsea Stellick sees value in Valeo Pharma (Valeo Pharma Stock Quote, C... Read More
Montreal-based Valeo Pharma (Valeo Pharma Stock Quote, Chart, News, Analysts, Financials CSE:VPH) re... Read More
Industrial Alliance Capital Markets analyst Chelsea Stellick is sticking with her “Buy” rating o... Read More
Specialty Pharma company Valeo Pharma (Valeo Pharma Stock Quote, Chart, News CSE:VPH) has a number o... Read More